ONMD

MKT CAP:$36M

OneMedNet Corporation

Market Cap

$36M

Healthcare·Medical - Healthcare Information Services·🇺🇸 United States·NASDAQ

Healthcare·Medical·🇺🇸·NASDAQ

Stock Price

$0.89-$0.33 (-26.83%)

Apr 22, 2026

Company Details

OneMedNet Corporation provides clinical imaging solutions. It offers iRWD, a solution that utilizes AI to securely de-identify, search, and curate imaging data for its partner network consisting of medical and academic research institutions...

CEO

Aaron Green

IPO Date

Jun 24, 2021

Website

www.onemednet.com

Key Metrics TTM

Revenue

$1M

+111.4% YoY

Net Income

-$3M

EPS (Diluted)

-$0.06

Free Cash Flow

-$8M

Revenue / Share

$0.03

Gross Margin

-37.0%

Operating Margin

-711.3%

Net Margin

-206.1%

FCF Margin

-553.1%

P/S

26.4x

P/E

—

Earnings Reports

FY 2025

Mar 30, 2026

$1M+111.4%EPS -$0.06

Q4 2025

Mar 30, 2026

$890.0K+3323.1%EPS -$0.06

Q3 2025

Nov 14, 2025

$177.0K+24.6%EPS -$0.02

Q2 2025

Aug 13, 2025

$155.0K-31.7%EPS $0.08

Q1 2025

May 14, 2025

$137.0K-44.8%EPS -$0.06

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q3 21	$197.1K	-$83.4K	-$98.7K
Q4 21	$398.7K	$31.8K	-$415.3K
Q2 22	$279.9K	-$89.0K	-$794.5K
Q4 22	$1M	$745.6K	-$4M
Q1 23	$200.0K	-$89.0K	-$1M
Q2 23	$173.0K	-$57.0K	-$2M
Q3 23	$326.0K	$33.0K	-$2M
Q4 23	$340.7K	$3.4K	-$4M
Q1 24	$248.0K	-$69.0K	-$2M
Q2 24	$227.0K	-$102.0K	-$2M
Q3 24	$142.0K	-$84.0K	-$2M
Q4 24	$26.0K	-$52.0K	-$3M
Q1 25	$137.0K	-$224.0K	-$2M
Q2 25	$155.0K	-$241.0K	-$2M
Q3 25	$177.0K	-$232.0K	-$2M
Q4 25	$890.0K	$194.0K	-$3M

Valuation

Quarter	P/S	P/E
Q3 21	—	—
Q4 21	—	—
Q2 22	—	—
Q4 22	117.0x	—
Q1 23	120.0x	—
Q2 23	145.9x	—
Q3 23	129.1x	—
Q4 23	17.4x	—
Q1 24	16.5x	—
Q2 24	22.8x	—
Q3 24	17.9x	—
Q4 24	63.8x	—
Q1 25	28.5x	—
Q2 25	42.3x	—
Q3 25	78.9x	—
Q4 25	45.3x	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q1 22	-$1M	-$1M
Q2 22	-$151.7K	-$151.7K
Q3 22	-$350.9K	-$350.9K
Q4 22	-$143.9K	-$143.9K
Q1 23	-$1M	-$1M
Q2 23	-$964.0K	-$971.0K
Q3 23	-$1M	-$1M
Q4 23	$13M	$13M
Q1 24	-$2M	-$2M
Q2 24	-$2M	-$2M
Q3 24	-$2M	-$2M
Q4 24	-$2M	-$2M
Q1 25	-$2M	-$2M
Q2 25	-$2M	-$2M
Q3 25	-$2M	-$2M
Q4 25	-$2M	-$2M

Capital Expenditures

Quarter	CapEx
Q1 22	$17.0K
Q2 22	$3
Q3 22	$4
Q4 22	$4
Q1 23	$0
Q2 23	$7.0K
Q3 23	$21.0K
Q4 23	$15.0K
Q1 24	$6.0K
Q2 24	$1.0K
Q3 24	$9.0K
Q4 24	$35.0K
Q1 25	$5.0K
Q2 25	$3.0K
Q3 25	$0
Q4 25	$5.0K

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q1 23	+1.5%	+464.2%
Q2 23	-56.6%	+114.2%
Q3 23	+16.5%	+109.7%
Q4 23	-70.4%	-20.1%
Q1 24	+24.0%	+40.7%
Q2 24	+31.2%	+53.7%
Q3 24	-56.4%	+12.3%
Q4 24	-92.4%	-37.4%
Q1 25	-44.8%	+0.5%
Q2 25	-31.7%	-17.3%
Q3 25	+24.6%	-4.6%
Q4 25	+3323.1%	+49.9%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q1 22	$10.3K	—
Q2 22	$0	0.0%
Q3 22	$0	—
Q4 22	$0	0.0%
Q1 23	$368.0K	184.0%
Q2 23	$280.0K	161.8%
Q3 23	$798.0K	244.8%
Q4 23	-$888.6K	-260.8%
Q1 24	$137.0K	55.2%
Q2 24	$103.0K	45.4%
Q3 24	$207.0K	145.8%
Q4 24	$181.0K	696.2%
Q1 25	$208.0K	151.8%
Q2 25	$197.0K	127.1%
Q3 25	$0	0.0%
Q4 25	$1M	166.9%

OpEx Breakdown

Quarter	R&D	G&A	S&M	SG&A
Q3 21	$173.1K	$368.8K	$93.6K	—
Q4 21	$149.8K	$271.3K	$279.6K	—
Q2 22	$217.7K	$819.2K	$154.8K	—
Q4 22	$242.3K	$7M	$369.4K	—
Q1 23	$582.0K	$2M	$259.0K	—
Q2 23	$579.0K	$3M	$311.0K	—
Q3 23	$405.0K	$1M	$243.0K	—
Q4 23	$498.5K	$3M	$298.2K	—
Q1 24	$445.0K	$1M	$229.0K	—
Q2 24	$383.0K	$2M	$253.0K	—
Q3 24	$298.0K	$2M	$140.0K	—
Q4 24	$340.0K	—	—	$2M
Q1 25	$348.0K	$1M	$290.0K	—
Q2 25	$382.0K	$1M	$257.0K	—
Q3 25	$323.0K	—	—	$2M
Q4 25	$462.0K	$2M	$421.0K	—

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 22	$159.1K	$0	$159.1K
Q2 22	$7.5K	$0	$7.5K
Q3 22	$312.3K	$0	$312.3K
Q4 22	$30.9K	$0	$30.9K
Q1 23	$145.1K	$0	$145.1K
Q2 23	$3.4K	$0	$3.4K
Q3 23	$611.8K	$0	$611.8K
Q4 23	$47.0K	$0	$47.0K
Q1 24	$174.0K	$0	$174.0K
Q2 24	$407.0K	$0	$407.0K
Q3 24	$2M	$2M	$4M
Q4 24	$172.0K	$3M	$3M
Q1 25	$144.0K	$793.0K	$937.0K
Q2 25	$122.0K	$2M	$2M
Q3 25	$149.0K	$0	$149.0K
Q4 25	$585.0K	$506.0K	$1M

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q3 21	15M	—	—
Q4 21	15M	0.0%	—
Q2 22	15M	0.0%	—
Q4 22	15M	+3.0%	—
Q1 23	20M	+30.1%	+34.1%
Q2 23	28M	+39.5%	+87.1%
Q3 23	28M	0.0%	+87.1%
Q4 23	15M	-45.0%	-0.2%
Q1 24	24M	+53.9%	+18.1%
Q2 24	24M	+1.1%	-14.5%
Q3 24	28M	+16.5%	-0.4%
Q4 24	28M	+0.4%	+81.9%
Q1 25	34M	+21.9%	+44.0%
Q2 25	38M	+12.6%	+60.4%
Q3 25	38M	0.0%	+37.8%
Q4 25	45M	+16.0%	+59.2%

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q3 21	—	—
Q4 21	—	—
Q2 22	—	—
Q4 22	—	—
Q1 23	—	—
Q2 23	—	—
Q3 23	—	—
Q4 23	—	—
Q1 24	—	—
Q2 24	—	—
Q3 24	—	—
Q4 24	$1.2K	22
Q1 25	$6.2K	22
Q2 25	$7.0K	22
Q3 25	$8.0K	22
Q4 25	$38.7K	23

Revenue / Employee